Cargando…
The Impact of Lab4 Probiotic Supplementation in a 90-Day Study in Wistar Rats
The anti-inflammatory and cholesterol lowering capabilities of probiotic bacteria highlight them as potential prophylactics against chronic inflammatory diseases, particularly cardiovascular disease. Previous studies in silico, in vitro, and in vivo suggest that the Lab4 probiotic consortium may har...
Autores principales: | Webberley, Thomas S., Masetti, Giulia, Baker, Laura M., Dally, Jordanna, Hughes, Timothy R., Marchesi, Julian R., Jack, Alison A., Plummer, Sue F., Ramanathan, Guru, Facey, Paul D., Michael, Daryn R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656110/ https://www.ncbi.nlm.nih.gov/pubmed/34901123 http://dx.doi.org/10.3389/fnut.2021.778289 |
Ejemplares similares
-
Assessment of Lab4P Probiotic Effects on Cognition in 3xTg-AD Alzheimer’s Disease Model Mice and the SH-SY5Y Neuronal Cell Line
por: Webberley, Thomas S., et al.
Publicado: (2023) -
Anti-Atherogenic Actions of the Lab4b Consortium of Probiotics In Vitro
por: O’Morain, Victoria L., et al.
Publicado: (2023) -
The Impact of Probiotic Supplementation on Cognitive, Pathological and Metabolic Markers in a Transgenic Mouse Model of Alzheimer’s Disease
por: Webberley, Thomas S., et al.
Publicado: (2022) -
Probiotics reduce self-reported symptoms of upper respiratory tract infection in overweight and obese adults: should we be considering probiotics during viral pandemics?
por: Mullish, Benjamin H., et al.
Publicado: (2021) -
Daily supplementation with the Lab4P probiotic consortium induces significant weight loss in overweight adults
por: Michael, D. R., et al.
Publicado: (2021)